Tirofiban Hydrochloride API

Name	Tirofiban hydrochloride
Chinese name	盐酸替罗非班
Cas Number	150915-40-5
Source	India
Qualifications	USDMF/-/-/-/-

Tirofiban hydrochloride is a cardiovascular drug developed by Merck in the United States. As a reversible non-peptide platelet GPIIb/IIIa receptor antagonist, it was listed in China in August 2004 and is currently The only platelet model GPIIb/IIIa receptor antagonist, clinically used to treat acute coronary syndromes, including patients with unstable angina or myocardial infarction without Q-wave, as well as percutaneous transluminal coronary angioplasty or atherosclerotic plaque In patients undergoing resection, the drug has a unique mechanism of action, has a high degree of selectivity and specificity for platelet GPIIb/IIIa receptors, reversibly inhibits platelet aggregation, has short half-life, no antigenicity, no adverse reactions, accurate clinical efficacy, and safety Well, it is a very promising therapeutic drug.

Hot Tags: tirofiban hydrochloride api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Gabapentin API, Rasagiline Mesylate API, Ticagrelor API, Troxagliptin Succinate API, Fulvestrant API, Ulipristal Acetate API

• Previous: Amisulpride API
• Next: Meta-hydroxylamine Bitartrate API